Kezar Life Sciences, Inc.

This early-stage study tested a new drug called KZR-261 in 61 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors. The trial was terminated early, s…

This study tested an experimental drug, zetomipzomib, in people with active lupus nephritis (kidney inflammation caused by lupus). The goal was to see if the drug could improve kidney function better than a placebo over 52 weeks. The trial was stopped early, and results are not y…